by Georgia Institute of Technology Researcher Daryll Vanover works with the nebulizer he adapted to test a new mRNA-based treatment for flu and Covid-19. The team used mRNA technology to code for a protein called Cas13a that destroys parts of the RNA genetic code that viruses use to replicate in cells in the lungs. It was...
